344 related articles for article (PubMed ID: 11011445)
1. [Diagnostic algorithm based on a multivariate model to reduce the percentage of negative prostatic biopsies in patients with changed PSA or suspicious rectal palpation].
Valer Algarabel J; Agüera Fernández L; Adot Zurbano JM; Virseda Chamorro M; Marcos Díez J; Gómez López A; Alpuente Román C
Actas Urol Esp; 2000; 24(7):549-59. PubMed ID: 11011445
[TBL] [Abstract][Full Text] [Related]
2. Prostate cancer screening within a prostate specific antigen range of 3 to 3.9 ng./ml.: a comparison of digital rectal examination and free prostate specific antigen as supplemental screening tests.
Mäkinen T; Tammela TL; Hakama M; Stenman UH; Rannikko S; Aro J; Juusela H; Määttänen L; Auvinen A
J Urol; 2001 Oct; 166(4):1339-42. PubMed ID: 11547069
[TBL] [Abstract][Full Text] [Related]
3. [Prospective validation of a nomogram predictive of a positive initial prostate biopsy].
Ramírez-Backhaus M; Bahilo P; Arlandis S; Santamaría Navarro C; Pontones Moreno JL; Jiménez-Cruz F
Actas Urol Esp; 2010 Jan; 34(1):35-42. PubMed ID: 20223131
[TBL] [Abstract][Full Text] [Related]
4. Determination of the percentage of free prostate-specific antigen helps to avoid unnecessary biopsies in men with normal rectal examinations and total prostate-specific antigen of 4-10 ng/ml.
Martínez-Piñeiro L; Tabernero A; Contreras T; Madero R; Lozano D; López-Tello J; Alonso-Dorrego JM; Picazo ML; González Gancedo P; Martínez-Piñeiro JA; de La Peña JJ
Eur Urol; 2000 Mar; 37(3):289-96. PubMed ID: 10720854
[TBL] [Abstract][Full Text] [Related]
5. Diagnosis of prostatic carcinoma: the yield of serum prostate specific antigen, digital rectal examination and transrectal ultrasonography.
Ellis WJ; Chetner MP; Preston SD; Brawer MK
J Urol; 1994 Nov; 152(5 Pt 1):1520-5. PubMed ID: 7523710
[TBL] [Abstract][Full Text] [Related]
6. [Yield of ultrasonography-guided transrectal biopsy in the diagnosis of carcinoma of the prostate].
Fernández González I; Ruiz Rubio JL; Llorente Abarca C; Aramburu González JA; Montes Díaz MJ; Herrero Payo A; Sánchez Sánchez E; Berenguer Sánchez A
Arch Esp Urol; 1995; 48(6):587-94. PubMed ID: 7544968
[TBL] [Abstract][Full Text] [Related]
7. [Clinical and analytical parameters that might indicate a second biopsy in patient with high PSA and previously negative biopsy].
Valer Algarabel J; Agüera Fernández L; Adot Zurbano JM; Virseda Chamorro M; Marcos Díaz J; Gómez López A; Alpuente Román C; Plaza Martos JA
Actas Urol Esp; 2002 Mar; 26(3):196-203. PubMed ID: 12053520
[TBL] [Abstract][Full Text] [Related]
8. Prospective evaluation of prostate specific antigen and prostate specific antigen density in the detection of nonpalpable and stage T1C carcinoma of the prostate.
Presti JC; Hovey R; Carroll PR; Shinohara K
J Urol; 1996 Nov; 156(5):1685-90. PubMed ID: 8863571
[TBL] [Abstract][Full Text] [Related]
9. Prostate cancer detection at low prostate specific antigen.
Schröder FH; van der Cruijsen-Koeter I; de Koning HJ; Vis AN; Hoedemaeker RF; Kranse R
J Urol; 2000 Mar; 163(3):806-12. PubMed ID: 10687982
[TBL] [Abstract][Full Text] [Related]
10. Optimal predictors of prostate cancer on repeat prostate biopsy: a prospective study of 1,051 men.
Djavan B; Zlotta A; Remzi M; Ghawidel K; Basharkhah A; Schulman CC; Marberger M
J Urol; 2000 Apr; 163(4):1144-8; discussion 1148-9. PubMed ID: 10737484
[TBL] [Abstract][Full Text] [Related]
11. [The role of the absolute value and "density" of the prostate-specific antigen estimated echographically in the selection of patients to undergo a biopsy in suspected prostatic carcinoma. A comparison between PSA, palpation and echography in 95 patients undergoing echo-guided endorectal prostatic biopsy].
Di Donna A; Bazzocchi M; Guerra UP; Bendini M; De Biasi F; Caminiti F; Delendi M
Radiol Med; 1993; 85(1-2):84-9. PubMed ID: 7683136
[TBL] [Abstract][Full Text] [Related]
12. Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: results of a multicenter clinical trial of 6,630 men.
Catalona WJ; Richie JP; Ahmann FR; Hudson MA; Scardino PT; Flanigan RC; DeKernion JB; Ratliff TL; Kavoussi LR; Dalkin BL; Waters WB; MacFarlane MT; Southwick PC
J Urol; 1994 May; 151(5):1283-90. PubMed ID: 7512659
[TBL] [Abstract][Full Text] [Related]
13. [Clinical utility of available diagnostic tests in prostatic carcinoma. Results of 500 biopsies. II. Rectal palpation, PSA, and transrectal echography].
Rodríguez Rodríguez R; Mayayo Dehesa T; Galbis Sanjuan F; Jiménez Cidre M; Burgos Revilla FJ; Gómez dos Santos V; García González R
Arch Esp Urol; 1997 May; 50(4):339-45. PubMed ID: 9313042
[TBL] [Abstract][Full Text] [Related]
14. Systematic prostatic biopsies in 100 men with no suspicion of cancer on digital rectal examination.
Vallancien G; Prapotnich D; Veillon B; Brisset JM; Andre-Bougaran J
J Urol; 1991 Nov; 146(5):1308-12. PubMed ID: 1719243
[TBL] [Abstract][Full Text] [Related]
15. Comparison of Digital Rectal Examination and Serum Prostate Specific Antigen in the Early Detection of Prostate Cancer: Results of a Multicenter Clinical Trial of 6,630 Men.
Catalona WJ; Richie JP; Ahmann FR; Hudson MA; Scardino PT; Flanigan RC; DeKernion JB; Ratliff TL; Kavoussi LR; Dalkin BL; Waters WB; MacFarlane MT; Southwick PC
J Urol; 2017 Feb; 197(2S):S200-S207. PubMed ID: 28012755
[TBL] [Abstract][Full Text] [Related]
16. Prostate specific antigen density of the transition zone for early detection of prostate cancer.
Djavan B; Zlotta AR; Byttebier G; Shariat S; Omar M; Schulman CC; Marberger M
J Urol; 1998 Aug; 160(2):411-8; discussion 418-9. PubMed ID: 9679889
[TBL] [Abstract][Full Text] [Related]
17. [Results of a series of transrectal ultrasound guided biopsy of the prostate in 6000 patients. Part I: pathology, digital rectal examination, transrectal ultrasound, and PSA].
Rodríguez-Patrón Rodríguez R; Mayayo Dehesa T; Alonso González M; Burgos Revilla FJ; Lennie Zucharino A
Arch Esp Urol; 2005 Sep; 58(7):611-22. PubMed ID: 16294783
[TBL] [Abstract][Full Text] [Related]
18. Prospective evaluation of prostate specific antigen (PSA), PSA density, free-to-total PSA ratio and a new formula (prostate malignancy index) for detecting prostate cancer and preventing negative biopsies in patients with normal rectal examinations and intermediate PSA levels.
Dinçel C; Caşkurlu T; Taşçi AI; Cek M; Sevin G; Fazlioğlu A
Int Urol Nephrol; 1999; 31(4):497-509. PubMed ID: 10668945
[TBL] [Abstract][Full Text] [Related]
19. Comparison of percent free prostate specific antigen and prostate specific antigen density as methods to enhance prostate specific antigen specificity in early prostate cancer detection in men with normal rectal examination and prostate specific antigen between 4.1 and 10 ng./ml.
Morote J; Raventós CX; Lorente JA; Lopez-Pacios MA; Encabo G; de Torres I; Andreu J
J Urol; 1997 Aug; 158(2):502-4. PubMed ID: 9224333
[TBL] [Abstract][Full Text] [Related]
20. Comparison of prostate specific antigen concentration versus prostate specific antigen density in the early detection of prostate cancer: receiver operating characteristic curves.
Catalona WJ; Richie JP; deKernion JB; Ahmann FR; Ratliff TL; Dalkin BL; Kavoussi LR; MacFarlane MT; Southwick PC
J Urol; 1994 Dec; 152(6 Pt 1):2031-6. PubMed ID: 7525994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
